estradiol vs etonogestrel
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of estradiol and etonogestrel. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
moderate Known Drug Interaction
Counsel women to use an alternative non-hormonal method of contraception or a back-up method when enzyme inducers are used with Etonogestrel and ethinyl estradiol vaginal ring, and to continue back-up non-hormonal contraception for 28 days after discontinuing the enzyme inducer to ensure contraceptive reliability. Note: Etonogestrel and ethinyl estradiol vaginal ring may interfere with the correct placement and position of certain female barrier methods such as a diaphragm or female condom. These methods are not recommended as back-up methods with Etonogestrel and ethinyl estradiol vaginal...
Estrace, Vivelle-Dot
Nexplanon
Iclevia is a birth control pill. It contains two hormones, a progestin and an estrogen, that work together to prevent pregnancy.
Etonogestrel and ethinyl estradiol vaginal ring is a birth control ring. It prevents pregnancy by releasing hormones into your body.
Iclevia is used by women who can get pregnant to prevent pregnancy. It contains two types of hormones. These hormones stop you from releasing an egg and also change the lining of your uterus, which prevents pregnancy.
This vaginal ring is used by women of reproductive age to prevent pregnancy. It contains a combination of estrogen and progestin hormones. These hormones stop you from getting pregnant.
Iclevia contains two hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen). These hormones prevent pregnancy by stopping ovulation (the release of an egg from the ovary). They also change the lining of the uterus to prevent a fertilized egg from implanting.
The ring releases etonogestrel and ethinyl estradiol into your body. These hormones prevent ovulation (the release of an egg from the ovary). They also change the lining of your uterus, making it harder for a fertilized egg to implant.
- • Headache
- • Heavy menstrual bleeding
- • Nausea
- • Painful periods
- • Acne
- • Vaginal infection
- • Headache (including migraine)
- • Mood changes (like depression or mood swings)
- • Problems with the ring (like discomfort or it coming out)
- • Nausea or vomiting
- Product Adhesion Issue 5,172
- Headache 5,036
- Nausea 4,754
- Fatigue 4,511
- Pain 3,480
- Product Quality Issue 5,554
- Complication Associated With Device 5,228
- Device Difficult To Use 4,562
- Device Breakage 4,501
- Incorrect Product Administration Duration 3,644
Cigarette smoking increases your risk of serious heart problems from birth control pills. This risk is higher if you are over 35 and smoke more cigarettes. You should not take Iclevia if you are over 35 and smoke.
Cigarette smoking increases your risk of serious heart problems from this medicine. This risk is higher if you are over 35 and smoke. If you are over 35 and smoke, you should not use this ring.
Do not use Iclevia if you are pregnant. If you become pregnant while taking Iclevia, stop taking it right away. Iclevia can reduce milk production, so you may want to use a different birth control method while breastfeeding.
Do not use this ring if you are pregnant. Small amounts of the hormones in this ring can pass into breast milk. This medicine may also reduce milk production.
How to Read This estradiol vs etonogestrel Comparison
estradiol is classified in the Estrogen Hormone drug class, while etonogestrel sits within the Progestin (Implant) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, estradiol has 22,953 submissions while etonogestrel has 23,489. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known moderate interaction flagged in FDA labeling, attributed to certain medications can speed up how the body breaks down birth control hormones. this makes the birth control less effective and increases the risk of pregnancy.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for estradiol or etonogestrel.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.